603716 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Thalys Medical Technology Group, Inc. engages in the research, development, production and sale of in vitro diagnostic products. The company also involves in the provision of medical testing marketing services. Its products include automatic coagulation analyzers, coagulation reagents, automatic fluorescence immunoassay analyzers, blood gas detection analyzers and biochemical analysis systems. The company was founded on February 23, 2004 and is headquartered in Wuhan, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
603716 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company